scholarly journals Curative effect assessment of immunotherapy for non‐small cell lung cancer: The “blind area” of Immune Response Evaluation Criteria in Solid Tumors (iRECIST)

2019 ◽  
Vol 10 (4) ◽  
pp. 587-592 ◽  
Author(s):  
Peng Song ◽  
Jingcheng Zhang ◽  
Congcong Shang ◽  
Li Zhang
Keyword(s):  
Lung Cancer ◽  
Immune Response ◽  
Evaluation Criteria ◽  
Small Cell ◽  
Response Evaluation ◽  
Small Cell Lung ◽  
Curative Effect ◽  
Effect Assessment ◽  
Blind Area ◽  
Response Evaluation Criteria

Practical consensus recommendations - Current role of immune response evaluation criteria in solid tumors criteria in the management of cancer patients receiving immunotherapy

2019 ◽  
Vol 4 ◽  
pp. 21-23
Author(s):  
Purvish M. Parikh ◽  
T. P. Sahoo ◽  
Randeep Singh ◽  
Bahl Ankur ◽  
Talvar Vineet ◽  
...  
Keyword(s):  
Immune Response ◽  
Solid Tumors ◽  
Evaluation Criteria ◽  
Supporting Evidence ◽  
Response Evaluation ◽  
Consensus Recommendation ◽  
Current Role ◽  
New Class ◽  
Response Evaluation Criteria

Response evaluation criteria in solid tumors (RECIST) are a method used to evaluate and document the response to cancer treatment in solid tumors. The availability of a new class of immuneoncology drugs has resulted in the need to modify RECIST criteria methodology. The first leadership immuno-oncology network (LION) master course brought together experts in oncology and immuno-oncology. Six questions were put to the experts and their opinion, supporting evidence, and experience were discussed to arrive at a practical consensus recommendation. n this nascent field, the availability of a practical consensus recommendation developed by experts in the field is of immense value to the community oncologist and other health-care consultants.

scholarly journals An Immune Response Enriched 72-Gene Prognostic Profile for Early-Stage Non–Small-Cell Lung Cancer

2008 ◽  
Vol 15 (1) ◽  
pp. 284-290 ◽  
Author(s):  
Paul Roepman ◽  
Jacek Jassem ◽  
Egbert F. Smit ◽  
Thomas Muley ◽  
Jacek Niklinski ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Immune Response ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Early Stage ◽  
Small Cell ◽  
Small Cell Lung ◽  
Prognostic Profile

scholarly journals The immune response‐related mutational signatures and driver genes in non‐small‐cell lung cancer

2019 ◽  
Vol 110 (8) ◽  
pp. 2348-2356 ◽  
Author(s):  
Hao Chen ◽  
Wei Chong ◽  
Changcai Teng ◽  
Yueliang Yao ◽  
Xin Wang ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Immune Response ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Mutational Signatures ◽  
Driver Genes
Sign in / Sign up

Export Citation Format

Share Document